Efficacy and Safety of Switching from Ranibizumab to Brolucizumab in Age-Related Macular Degeneration: Multicenter Real-World Outcomes.

Clin Ophthalmol · 2025 · PMC12517302 · PMID 41089879

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The p-value also indicates a statistically highly significant result, suggesting that it is extremely unlikely that this correlation occurred by chance ( Figures 2 and 3 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.